Rani Therapeutics Holdings, Inc.
RANIRani Therapeutics is a clinical-stage biotherapeutics company developing a proprietary platform for the oral delivery of biologics and drugs traditionally administered via injection.
Table of contents
Earnings
Next report
Aug 6, 2026 (In 1 week)Competitors
By market cap
By revenue growth
Profile
Rani Therapeutics is a clinical-stage biotherapeutics company developing a proprietary platform for the oral delivery of biologics and drugs traditionally administered via injection. Its core value proposition centers on the RaniPill capsule, which is designed to navigate the gastrointestinal environment and automatically deliver therapeutic payloads into the intestinal wall to achieve high bioavailability. The company aims to disrupt the injectable biologics market by improving patient compliance and expanding access to chronic disease treatments.
A clinical-stage innovator in the oral biologics space with a vertically integrated manufacturing strategy and a proprietary mechanical delivery mechanism that achieves significantly higher bioavailability than chemistry-based oral alternatives.
Questions, answered.
- What is Rani Therapeutics Holdings, Inc.'s market cap?
- Rani Therapeutics Holdings, Inc. (RANI) has a market capitalization of $91.0M and trades on NASDAQ.
- Who are Rani Therapeutics Holdings, Inc.'s competitors?
- Rani Therapeutics Holdings, Inc.'s key competitors include Oramed Pharmaceuticals, Inc., Protagonist Therapeutics, Inc., Entera Bio Ltd., and others. These companies compete in similar markets and product categories.
- Who does Rani Therapeutics Holdings, Inc. partner with?
- Rani Therapeutics Holdings, Inc.'s notable partners include Chugai Pharmaceutical Co., Ltd., ProGen Co., Ltd., Celltrion, Inc., and others.
- What subsidiaries does Rani Therapeutics Holdings, Inc. have?
- Rani Therapeutics Holdings, Inc.'s subsidiaries include Rani Management Services (RMS), Rani LLC.
- Where is Rani Therapeutics Holdings, Inc. headquartered?
- Rani Therapeutics Holdings, Inc. is headquartered in United States of America and employs approximately 140 people. It has been publicly traded since 2021.